Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ingenol Mebutate (Perrigo) vs Picato in Actinic Keratosis
NCT02385318Phase 3Completed
- Sponsor
- Padagis
- Start
- Feb 2015
- Primary completion
- Dec 2015
- Modality
- Peptides, Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of ingenol mebutate in actinic keratosis (AK) (3 arms), sponsored by Padagis. Primary endpoint: Number of Participants With Complete Clearance (Absence) of Actinic Keratosis Lesions at Day 57. Started Feb 2015; status: completed.
02
Drugs
ingenol mebutate
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT02385318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02385318.